{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:04:26Z","timestamp":1783764266572,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korean government","award":["2022\u20130-00621"],"award-info":[{"award-number":["2022\u20130-00621"]}]},{"name":"grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea","award":["RS-2023-00262087"],"award-info":[{"award-number":["RS-2023-00262087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85672-1","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:59:05Z","timestamp":1737010745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between triglyceride\/high density lipoprotein ratio and incidence risk of Parkinson\u2019s disease: a population-based cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Yoonkyung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-762X","authenticated-orcid":false,"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"85672_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"J Steinmetz","year":"2024","unstructured":"Steinmetz, J. et al. (ed, D.) Global, regional, and national burden of disorders affecting the nervous system,1990\u20132021: A systematic analysis for the global burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3 (2024).","journal-title":"Lancet Neurol."},{"key":"85672_CR2","doi-asserted-by":"publisher","first-page":"e059548","DOI":"10.1136\/bmjopen-2021-059548","volume":"12","author":"S Kang","year":"2022","unstructured":"Kang, S. et al. Burden of neurological diseases in Asia from 1990 to 2019: A systematic analysis using the global burden of Disease Study data. BMJ Open. 12, e059548. https:\/\/doi.org\/10.1136\/bmjopen-2021-059548 (2022).","journal-title":"BMJ Open."},{"key":"85672_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1212\/WNL.0b013e318198db11","volume":"72","author":"E Tolosa","year":"2009","unstructured":"Tolosa, E., Gaig, C., Santamar\u00eda, J. & Compta, Y. Diagnosis and the premotor phase of Parkinson disease. Neurology 72, 12\u2013S20. https:\/\/doi.org\/10.1212\/WNL.0b013e318198db11 (2009).","journal-title":"Neurology"},{"key":"85672_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3988\/jcn.2023.0336","volume":"20","author":"J Lee","year":"2024","unstructured":"Lee, J., Kim, J. J., Lyoo, C. H. & Kim, Y. J. Mitochondrial-membrane-protein-Associated Neurodegeneration in Longitudinal magnetic resonance imaging over 11 years of Follow-Up. J. Clin. Neurol. 20, 220\u2013222 (2024).","journal-title":"J. Clin. Neurol."},{"key":"85672_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","volume":"384","author":"AHV Schapira","year":"2014","unstructured":"Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T. & Bezard, E. Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: fFture therapeutic perspectives. Lancet 384, 545\u2013555. https:\/\/doi.org\/10.1016\/S0140-6736(14)61010-2 (2014).","journal-title":"Lancet"},{"key":"85672_CR6","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz, H. E. Insulin resistance: Definition and consequences. Exp. Clin. Endocrinol. Diabetes. 109, S135\u2013S148. https:\/\/doi.org\/10.1055\/s-2001-18576 (2001).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"85672_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","volume":"1","author":"B Singh","year":"2010","unstructured":"Singh, B. & Saxena, A. Surrogate markers of insulin resistance: A review. World J. Diabetes. 1, 36\u201347. https:\/\/doi.org\/10.4239\/wjd.v1.i2.36 (2010).","journal-title":"World J. Diabetes"},{"key":"85672_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.20920","volume":"42","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi, E., McCullough, A. J. & Marchesini, G. Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology 42, 987\u20131000. https:\/\/doi.org\/10.1002\/hep.20920 (2005).","journal-title":"Hepatology"},{"key":"85672_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jiph.2022.06.014","volume":"15","author":"Y Chang","year":"2022","unstructured":"Chang, Y., Jeon, J., Song, T. J. & Kim, J. Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study. J. Infect. Public Health. 15, 837\u2013844. https:\/\/doi.org\/10.1016\/j.jiph.2022.06.014 (2022).","journal-title":"J. Infect. Public Health"},{"key":"85672_CR10","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2337\/dc22-0202","volume":"45","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Association between Insulin Resistance and Cardiovascular Disease Risk varies according to glucose tolerance status: A nationwide prospective cohort study. Diabetes Care. 45, 1863\u20131872. https:\/\/doi.org\/10.2337\/dc22-0202 (2022).","journal-title":"Diabetes Care"},{"key":"85672_CR11","doi-asserted-by":"publisher","unstructured":"Ormazabal, V. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol. 17 https:\/\/doi.org\/10.1186\/s12933-018-0762-4 (2018).","DOI":"10.1186\/s12933-018-0762-4"},{"key":"85672_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145\u2013146","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. Insulin resistance and Parkinson\u2019s disease: A new target for disease modification? Prog Neurobiol. 145\u2013146, 98\u2013120. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.10.001 (2016).","journal-title":"Prog Neurobiol."},{"key":"85672_CR13","doi-asserted-by":"publisher","first-page":"e12760","DOI":"10.1111\/nan.12760","volume":"48","author":"F Bassil","year":"2022","unstructured":"Bassil, F. et al. Impaired brain insulin signalling in Parkinson\u2019s disease. Neuropathol. Appl. Neurobiol. 48, e12760. https:\/\/doi.org\/10.1111\/nan.12760 (2022).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"85672_CR14","first-page":"152","volume":"153","author":"BG Baez-Duarte","year":"2017","unstructured":"Baez-Duarte, B. G. et al. Triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects. Gac Med. Mex. 153, 152\u2013158 (2017).","journal-title":"Gac Med. Mex"},{"key":"85672_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-021-01330-6","volume":"20","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Association of TyG index and TG\/HDL-C ratio with arterial stiffness progression in a non-normotensive population. Cardiovasc. Diabetol. 20, 134. https:\/\/doi.org\/10.1186\/s12933-021-01330-6 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"85672_CR16","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1194\/jlr.M040584","volume":"54","author":"M Murguia-Romero","year":"2013","unstructured":"Murguia-Romero, M. et al. Plasma triglyceride\/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J. Lipid Res. 54, 2795\u20132799. https:\/\/doi.org\/10.1194\/jlr.M040584 (2013).","journal-title":"J. Lipid Res."},{"key":"85672_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1475-2840-10-93","volume":"10","author":"JK Chiang","year":"2011","unstructured":"Chiang, J. K., Lai, N. S., Chang, J. K. & Koo, M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc. Diabetol. 10, 93. https:\/\/doi.org\/10.1186\/1475-2840-10-93 (2011).","journal-title":"Cardiovasc. Diabetol."},{"key":"85672_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-021-01377-5","volume":"20","author":"J Kim","year":"2021","unstructured":"Kim, J., Shin, S. J., Kim, Y. S. & Kang, H. T. Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults. Cardiovasc. Diabetol. 20, 183. https:\/\/doi.org\/10.1186\/s12933-021-01377-5 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"85672_CR19","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Cohort profile: The national health insurance service-national health screening cohort (NHIS-HEALS) in Korea. BMJ Open. 7, e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640 (2017).","journal-title":"BMJ Open."},{"key":"85672_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/jcpe.13373","volume":"47","author":"TJ Song","year":"2020","unstructured":"Song, T. J., Kim, J. W. & Kim, J. Oral health and changes in lipid profile: A nationwide cohort study. J. Clin. Periodontol. 47, 1437\u20131445. https:\/\/doi.org\/10.1111\/jcpe.13373 (2020).","journal-title":"J. Clin. Periodontol"},{"key":"85672_CR21","doi-asserted-by":"publisher","unstructured":"Woo, H. G., Chang, Y., Lee, J. S. & Song, T. J. Association of Tooth Loss with New-Onset Parkinson\u2019s Disease: A Nationwide Population-Based Cohort Study. Parkinsons Dis. 2020 (4760512). https:\/\/doi.org\/10.1155\/2020\/4760512 (2020).","DOI":"10.1155\/2020\/4760512"},{"key":"85672_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/JPER.20-0053","volume":"92","author":"Y Chang","year":"2021","unstructured":"Chang, Y., Woo, H. G., Lee, J. S. & Song, T. J. Better oral hygiene is associated with lower risk of stroke. J. Periodontol. 92, 87\u201394. https:\/\/doi.org\/10.1002\/JPER.20-0053 (2021).","journal-title":"J. Periodontol."},{"key":"85672_CR23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/jcpe.13304","volume":"47","author":"K Lee","year":"2020","unstructured":"Lee, K. et al. Oral health and gastrointestinal cancer: A nationwide cohort study. J. Clin. Periodontol. 47, 796\u2013808. https:\/\/doi.org\/10.1111\/jcpe.13304 (2020).","journal-title":"J. Clin. Periodontol."},{"key":"85672_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/HJH.0000000000003022","volume":"40","author":"J Kim","year":"2022","unstructured":"Kim, J., Kim, H. J., Jeon, J. & Song, T. J. Association between oral health and cardiovascular outcomes in patients with hypertension: A nationwide cohort study. J. Hypertens. 40, 374\u2013381. https:\/\/doi.org\/10.1097\/HJH.0000000000003022 (2022).","journal-title":"J. Hypertens."},{"key":"85672_CR25","doi-asserted-by":"publisher","first-page":"e0253769","DOI":"10.1371\/journal.pone.0253769","volume":"16","author":"TJ Song","year":"2021","unstructured":"Song, T. J., Chang, Y., Jeon, J. & Kim, J. Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study. PLoS One. 16, e0253769. https:\/\/doi.org\/10.1371\/journal.pone.0253769 (2021).","journal-title":"PLoS One"},{"key":"85672_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson, M. E., Carrozzino, D., Guidi, J. & Patierno, C. Charlson comorbidity index: A critical review of clinimetric properties. Psychother. Psychosom. 91, 8\u201335. https:\/\/doi.org\/10.1159\/000521288 (2022).","journal-title":"Psychother. Psychosom."},{"key":"85672_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00125-020-05112-9","volume":"63","author":"Y Chang","year":"2020","unstructured":"Chang, Y., Lee, J. S., Lee, K. J., Woo, H. G. & Song, T. J. Improved oral hygiene is associated with decreased risk of new-onset diabetes: A nationwide population-based cohort study. Diabetologia 63, 924\u2013933. https:\/\/doi.org\/10.1007\/s00125-020-05112-9 (2020).","journal-title":"Diabetologia"},{"key":"85672_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12877-019-1332-7","volume":"19","author":"JH Park","year":"2019","unstructured":"Park, J. H. et al. Trends in the incidence and prevalence of Parkinson\u2019s disease in Korea: A nationwide, population-based study. BMC Geriatr. 19, 320. https:\/\/doi.org\/10.1186\/s12877-019-1332-7 (2019).","journal-title":"BMC Geriatr."},{"key":"85672_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/diagnostics13050929","volume":"13","author":"CE Kosmas","year":"2023","unstructured":"Kosmas, C. E. et al. The Triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and Cardiovascular Disease. Diagnostics 13, 929 (2023).","journal-title":"Diagnostics"},{"key":"85672_CR30","doi-asserted-by":"publisher","first-page":"e17428","DOI":"10.1016\/j.heliyon.2023.e17428","volume":"9","author":"Y Chang","year":"2023","unstructured":"Chang, Y., Jeon, J., Song, T. J. & Kim, J. Association of triglyceride\/high-density lipoprotein cholesterol ratio with severe complications of COVID-19. Heliyon 9, e17428. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17428 (2023).","journal-title":"Heliyon"},{"key":"85672_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.hlc.2019.03.019","volume":"29","author":"R Sultani","year":"2020","unstructured":"Sultani, R. et al. Elevated triglycerides to high-density lipoprotein cholesterol (TG\/HDL-C) ratio predicts long-term mortality in high-risk patients. Heart Lung Circ. 29, 414\u2013421. https:\/\/doi.org\/10.1016\/j.hlc.2019.03.019 (2020).","journal-title":"Heart Lung Circ."},{"key":"85672_CR32","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2337\/dc08-0688","volume":"31","author":"JA Driver","year":"2008","unstructured":"Driver, J. A. et al. Prospective cohort study of type 2 diabetes and the risk of Parkinson\u2019s disease. Diabetes Care. 31, 2003\u20132005. https:\/\/doi.org\/10.2337\/dc08-0688 (2008).","journal-title":"Diabetes Care"},{"key":"85672_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu, G., Jousilahti, P., Bidel, S., Antikainen, R. & Tuomilehto, J. Type 2 diabetes and the risk of Parkinson\u2019s disease. Diabetes Care. 30, 842\u2013847. https:\/\/doi.org\/10.2337\/dc06-2011 (2007).","journal-title":"Diabetes Care"},{"key":"85672_CR34","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc10-1333","volume":"34","author":"E Schernhammer","year":"2011","unstructured":"Schernhammer, E., Hansen, J., Rugbjerg, K., Wermuth, L. & Ritz, B. Diabetes and the risk of developing Parkinson\u2019s disease in Denmark. Diabetes Care. 34, 1102\u20131108. https:\/\/doi.org\/10.2337\/dc10-1333 (2011).","journal-title":"Diabetes Care"},{"key":"85672_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist, M. L. et al. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat. Disord. 18, 753\u2013758. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.010 (2012).","journal-title":"Parkinsonism Relat. Disord"},{"key":"85672_CR36","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/mds.23855","volume":"26","author":"N Palacios","year":"2011","unstructured":"Palacios, N. et al. Obesity, diabetes, and risk of Parkinson\u2019s disease. Mov. Disord. 26, 2253\u20132259. https:\/\/doi.org\/10.1002\/mds.23855 (2011).","journal-title":"Mov. Disord"},{"key":"85672_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/mds.25016","volume":"27","author":"R Savica","year":"2012","unstructured":"Savica, R., Grossardt, B. R., Ahlskog, J. E. & Rocca, W. A. Metabolic markers or conditions preceding Parkinson\u2019s disease: A case-control study. Mov. Disord. 27, 974\u2013979. https:\/\/doi.org\/10.1002\/mds.25016 (2012).","journal-title":"Mov. Disord"},{"key":"85672_CR38","doi-asserted-by":"publisher","first-page":"e85781","DOI":"10.1371\/journal.pone.0085781","volume":"9","author":"L Lu","year":"2014","unstructured":"Lu, L. et al. Diabetes and risk of Parkinson\u2019s disease: An updated meta-analysis of case-control studies. PLoS One. 9, e85781. https:\/\/doi.org\/10.1371\/journal.pone.0085781 (2014).","journal-title":"PLoS One"},{"key":"85672_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.parkreldis.2009.02.013","volume":"15","author":"M D\u2019Amelio","year":"2009","unstructured":"D\u2019Amelio, M. et al. Diabetes preceding Parkinson\u2019s disease onset. A case-control study. Parkinsonism Relat. Disord. 15, 660\u2013664. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.02.013 (2009).","journal-title":"Parkinsonism Relat. Disord"},{"key":"85672_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315","author":"D Bosco","year":"2012","unstructured":"Bosco, D. et al. Dementia is associated with Insulin Resistance in patients with Parkinson\u2019s Disease. J. Neurol. Sci. 315, 39\u201343. https:\/\/doi.org\/10.1016\/j.jns.2011.12.008 (2012).","journal-title":"J. Neurol. Sci."},{"key":"85672_CR41","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3233\/jpd-191896","volume":"10","author":"S Molsberry","year":"2020","unstructured":"Molsberry, S. et al. Plasma metabolomic markers of insulin resistance and diabetes and rate of Incident Parkinson\u2019s Disease. J. Parkinsons Dis. 10, 1011\u20131021. https:\/\/doi.org\/10.3233\/jpd-191896 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"85672_CR42","doi-asserted-by":"publisher","unstructured":"Hong, X., Guo, W. & Li, S. Lower blood lipid level is associated with the occurrence of Parkinson\u2019s Disease: A meta-analysis and systematic review. Int. J. Clin. Pract. 2022 (9773038). https:\/\/doi.org\/10.1155\/2022\/9773038 (2022).","DOI":"10.1155\/2022\/9773038"},{"key":"85672_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12944-020-01284-w","volume":"19","author":"X Fu","year":"2020","unstructured":"Fu, X. et al. A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson\u2019s disease. Lipids Health Dis. 19, 97. https:\/\/doi.org\/10.1186\/s12944-020-01284-w (2020).","journal-title":"Lipids Health Dis."},{"key":"85672_CR44","doi-asserted-by":"publisher","unstructured":"Hong, C. T. et al. Insulin resistance promotes Parkinson\u2019s disease through aberrant expression of \u03b1-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 Signaling. Cells 9 https:\/\/doi.org\/10.3390\/cells9030740 (2020).","DOI":"10.3390\/cells9030740"},{"key":"85672_CR45","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/mds.26734","volume":"31","author":"P Svenningsson","year":"2016","unstructured":"Svenningsson, P. et al. Reduced incidence of Parkinson\u2019s disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study. Mov. Disord. 31, 1422\u20131423. https:\/\/doi.org\/10.1002\/mds.26734 (2016).","journal-title":"Mov. Disord"},{"key":"85672_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","volume":"25","author":"GA Badawi","year":"2017","unstructured":"Badawi, G. A., Abd El Fattah, M. A., Zaki, H. F., & El Sayed, M. I. Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson\u2019s disease. Inflammopharmacology 25, 369\u2013382. https:\/\/doi.org\/10.1007\/s10787-017-0331-6 (2017).","journal-title":"Inflammopharmacology"},{"key":"85672_CR47","doi-asserted-by":"publisher","unstructured":"Ruiz-Pozo, V. A. et al. The molecular mechanisms of the Relationship between insulin resistance and Parkinson\u2019s disease pathogenesis. Nutrients 15 https:\/\/doi.org\/10.3390\/nu15163585 (2023).","DOI":"10.3390\/nu15163585"},{"key":"85672_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30039","author":"A Zagare","year":"2024","unstructured":"Zagare, A. et al. Insulin resistance is a modifying factor for Parkinson\u2019s Disease. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.30039 (2024).","journal-title":"Mov. Disord."},{"key":"85672_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-023-01777-9","volume":"22","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease. Cardiovasc. Diabetol. 22, 118. https:\/\/doi.org\/10.1186\/s12933-023-01777-9 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"85672_CR50","doi-asserted-by":"publisher","first-page":"1180910","DOI":"10.3389\/fendo.2023.1180910","volume":"14","author":"B Song","year":"2023","unstructured":"Song, B. et al. A U-shaped association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of incident type 2 diabetes mellitus in Japanese men with normal glycemic levels: A population-based longitudinal cohort study. Front. Endocrinol. (Lausanne). 14, 1180910. https:\/\/doi.org\/10.3389\/fendo.2023.1180910 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"85672_CR51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2010.05.006","volume":"212","author":"WS Ryu","year":"2010","unstructured":"Ryu, W. S., Lee, S. H., Kim, C. K., Kim, B. J. & Yoon, B. W. Effects of low serum triglyceride on stroke mortality: A prospective follow-up study. Atherosclerosis 212, 299\u2013304. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.05.006 (2010).","journal-title":"Atherosclerosis"},{"key":"85672_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2261-14-143","volume":"14","author":"YT Cheng","year":"2014","unstructured":"Cheng, Y. T. et al. Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study. BMC Cardiovasc. Disord. 14, 143. https:\/\/doi.org\/10.1186\/1471-2261-14-143 (2014).","journal-title":"BMC Cardiovasc. Disord."},{"key":"85672_CR53","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1007\/s10072-022-06113-9","volume":"43","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. Lower serum triglyceride levels linked to more severe motor performance in Parkinson\u2019s disease. Neurol. Sci. 43, 5343\u20135353. https:\/\/doi.org\/10.1007\/s10072-022-06113-9 (2022).","journal-title":"Neurol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85672-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:59:12Z","timestamp":1737010752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85672-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85672"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85672-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2142"}}